An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines

(2021) Milena Sokolowska et al.   ALLERGY

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

(2021) Kathy Leung et al.   Eurosurveillance

COVID-19 vaccine: where are we now and where should we go?

(2021) Saman Soleimanpour et al.   Expert Review of Vaccines

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

(2021) Tom Shimabukuro et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK

(2021) Julian W. Tang et al.   JOURNAL OF INFECTION

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

(2021) Jerald Sadoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccinating Children against Covid-19 — The Lessons of Measles

(2021) Perri Klass et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Profile of the Obstetric Patients with SARS-CoV-2 Infection According to Country of Origin of the Publication: A Systematic Review of the Literature

(2021) Yolanda Cuñarro-López et al.   Journal of Clinical Medicine

Impact of COVID-19 Pandemic on Flu and COVID-19 Vaccination Intentions among University Students

(2021) Roberta Pastorino et al.   Vaccines

Development of mRNA Vaccines: Scientific and Regulatory Issues

(2021) Ivana Knezevic et al.   Vaccines

Optimising Vaccine Dose in Inoculation against SARS-CoV-2, a Multi-Factor Optimisation Modelling Study to Maximise Vaccine Safety and Efficacy

(2021) John Benest et al.   Vaccines

Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate

(2021) Larisa I. Karpenko et al.   Vaccines

Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

(2021) Alberto Cagigi et al.   Vaccines

A Rapid Systematic Review of Public Responses to Health Messages Encouraging Vaccination against Infectious Diseases in a Pandemic or Epidemic

(2021) Sadie Lawes-Wickwar et al.   Vaccines

Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys

(2021) Kailu Wang et al.   Vaccines

Nanomaterial Delivery Systems for mRNA Vaccines

(2021) Michael D. Buschmann et al.   Vaccines

The Use of Nanobiotechnology in Immunology and Vaccination

(2021) Reza Keikha et al.   Vaccines

A Predictive Model and Risk Factors for Case Fatality of COVID-19

(2021) Melchor Álvarez-Mon et al.   Journal of Personalized Medicine

Advanced Nanomaterials for Preparedness Against (Re‐)Emerging Viral Diseases

(2021) Eunjung Kim et al.   ADVANCED MATERIALS

Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination

(2021) Eun‐Ju Lee et al.   AMERICAN JOURNAL OF HEMATOLOGY

Allergische Reaktionen auf COVID-19-Impfstoffe – Evidenz und praxisorientiertes Vorgehen

(2021) L. Klimek et al.   INTERNIST

The US Regulatory System and COVID-19 Vaccines

(2021) Joshua M. Sharfstein et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy

(2021) Md. Muzahid Ahmed Ezaj et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

(2021) Olivier J Wouters et al.   LANCET

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

(2021) Denis Y Logunov et al.   LANCET

Tanzania refuses COVID-19 vaccines

(2021) Munyaradzi Makoni   LANCET

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2021) Zhiwei Wu et al.   LANCET INFECTIOUS DISEASES

Adjuvantation helps to optimise COVID-19 vaccine candidate

(2021) Jing-Xin Li et al.   LANCET INFECTIOUS DISEASES

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS‐CoV‐2, Covid‐19, and the debunking of conspiracy theories

(2021) Mohamad S. Hakim   REVIEWS IN MEDICAL VIROLOGY

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

(2021) Nicholas G. Davies et al.   SCIENCE

The pulmonary pathology of COVID-19

(2021) Hans Bösmüller et al.   VIRCHOWS ARCHIV

Covid-19: How the UK vaccine rollout delivered success, so far

(2021) Chris Baraniuk   BMJ-British Medical Journal

Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots

(2021) Jacqui Wise   BMJ-British Medical Journal

COVID-19: Imbalanced Immune Responses and Potential Immunotherapies

(2021) Bing Xie et al.   Frontiers in Immunology

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond

(2021) Emily Bettini et al.   Vaccines

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

(2021) Malik Sallam   Vaccines

Intention to Receive the COVID-19 Vaccination in China: Application of the Diffusion of Innovations Theory and the Moderating Role of Openness to Experience

(2021) Phoenix Kit-han Mo et al.   Vaccines

COVID-19 Vaccination: From Interesting Agent to the Patient

(2021) Anis Daou   Vaccines

Why It Is Important to Develop an Effective and Safe Pediatric COVID-19 Vaccine

(2021) Nicola Principi et al.   Vaccines

Advancements in mRNA Encoded Antibodies for Passive Immunotherapy

(2021) Cailin E. Deal et al.   Vaccines

The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation

(2021) Piotr Rzymski et al.   Vaccines

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

(2021) Christian Holm Hansen et al.   LANCET

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

(2021) Shabir A. Madhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19: What do we know about Sputnik V and other Russian vaccines?

(2021) Chris Baraniuk   BMJ-British Medical Journal

Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling

(2021) Neil J. Rowan et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

A Genomic Perspective on the Origin and Emergence of SARS-CoV-2

(2020) Yong-Zhen Zhang et al.   CELL

The Architecture of SARS-CoV-2 Transcriptome

(2020) Dongwan Kim et al.   CELL

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Rational Vaccine Design in the Time of COVID-19

(2020) Dennis R. Burton et al.   Cell Host & Microbe

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

(2020) Juanjuan Zhao et al.   CLINICAL INFECTIOUS DISEASES

Herd Immunity: Understanding COVID-19

(2020) Haley E. Randolph et al.   IMMUNITY

The SARS-CoV-2 outbreak: What we know

(2020) Di Wu et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection

(2020) Paul Kellam et al.   JOURNAL OF GENERAL VIROLOGY

The plight of essential workers during the COVID-19 pandemic

(2020) The Lancet   LANCET

The state of vaccine safety science: systematic reviews of the evidence

(2020) Matthew Z Dudley et al.   LANCET INFECTIOUS DISEASES

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

(2020) Patrick Peretti-Watel et al.   LANCET INFECTIOUS DISEASES

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

(2020) Dora Pinto et al.   NATURE

Structural basis of receptor recognition by SARS-CoV-2

(2020) Jian Shang et al.   NATURE

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

COVID-19 and non-communicable diseases

(2020) Rimesh Pal et al.   POSTGRADUATE MEDICAL JOURNAL

Development of an inactivated vaccine candidate for SARS-CoV-2

(2020) Qiang Gao et al.   SCIENCE

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

(2020) Stephen M. Kissler et al.   SCIENCE

Why the immune system fails to mount an adaptive immune response to a COVID‐19 infection

(2020) Pedram Ahmadpoor et al.   TRANSPLANT INTERNATIONAL

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions

(2020) Mohammed Uddin et al.   Viruses-Basel

Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis

(2020) Mohammed Iddir et al.   Nutrients

Depression and Anxiety in Hong Kong during COVID-19

(2020) Edmond Pui Hang Choi et al.   International Journal of Environmental Research and Public Health

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues

(2020) Meng-Yuan Li et al.   Infectious Diseases of Poverty

COVID-19 vaccines: breaking record times to first-in-human trials

(2020) Young Chan Kim et al.   npj Vaccines

A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?

(2020) Sung-Jae Kim et al.   Vaccines

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

(2020) Bette Korber et al.   CELL

IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study

(2020) Andrea Padoan et al.   CLINICA CHIMICA ACTA

The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States

(2020) Don Bambino Geno Tai et al.   CLINICAL INFECTIOUS DISEASES

Vaccine hesitancy: the next challenge in the fight against COVID-19

(2020) Amiel A. Dror et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Lessons for COVID-19 Immunity from Other Coronavirus Infections

(2020) Alan Sariol et al.   IMMUNITY

COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

(2020) Yang Song et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

(2020) Kizzmekia S. Corbett et al.   NATURE

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

(2020) F. Javier Ibarrondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Physical activity: Benefits and challenges during the COVID‐19 pandemic

(2020) Michael John Dwyer et al.   SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies

(2020) Lea Skak Filtenborg Frederiksen et al.   Frontiers in Immunology

COVID-19 and comorbidities: Deleterious impact on infected patients

(2020) Hasan Ejaz et al.   Journal of Infection and Public Health

COVID-19 Vaccine Frontrunners and Their Nanotechnology Design

(2020) Young Hun Chung et al.   ACS Nano

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

(2020) Denis Y Logunov et al.   LANCET

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines

(2020) Eric J. Kremer   MOLECULAR THERAPY

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

(2020) Ugur Sahin et al.   NATURE

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

(2020) Evan J. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

(2020) Cheryl Keech et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mechanisms of SARS-CoV-2 transmission and pathogenesis

(2020) Andrew G. Harrison et al.   TRENDS IN IMMUNOLOGY

Covid-19: Vaccine roll out could take a year and will require difficult prioritisation decisions

(2020) Elisabeth Mahase   BMJ-British Medical Journal

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses

(2020) Zeinab Abdelrahman et al.   Frontiers in Immunology

Aging in COVID-19: Vulnerability, immunity and intervention

(2020) Yiyin Chen et al.   AGEING RESEARCH REVIEWS

Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches

(2020) Magda Gioia et al.   BIOCHEMICAL PHARMACOLOGY

COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology

(2020) Hyun Jee Han et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

An integrative look at SARS‑CoV‑2 (Review)

(2020) Miguel Ortega et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic

(2020) Jung-Hyun Won et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Science and Evidence‐based Review and Approval of COVID‐19 Vaccines: A Statement of Support for the U.S. FDA

(2020) Sudhakar M. Pai et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Is there a role for childhood vaccination against COVID‐19?

(2020) Christiane Sigrid Eberhardt et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study

(2020) Wei Wang et al.   BMJ-British Medical Journal

SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments

(2020) Gisela Canedo-Marroquín et al.   Frontiers in Immunology

Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020

(2020) Wesley H. Self et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

(2020) Zoltán Kis et al.   Vaccines

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2

(2020) Reham M. Dawood et al.   Journal of Infection and Public Health

Coronavirus Disease 2019 and Vaccination of Children and Adolescents: Prospects and Challenges

(2020) Gregory D. Zimet et al.   JOURNAL OF PEDIATRICS

Herd Immunity

(2019) David R. Smith   VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE

mRNA vaccines — a new era in vaccinology

(2018) Norbert Pardi et al.   NATURE REVIEWS DRUG DISCOVERY

Novel viral vectors in infectious diseases

(2017) Ian R. Humphreys et al.   IMMUNOLOGY

The last major outbreak of smallpox (Yugoslavia, 1972): The importance of historical reminders

(2017) Milena Ilic et al.   Travel Medicine and Infectious Disease

Biological Age Predictors

(2017) Juulia Jylhävä et al.   EBioMedicine

The swine flu vaccine, public attitudes, and researcher interpretations: a systematic review of qualitative research

(2016) Benedicte Carlsen et al.   BMC HEALTH SERVICES RESEARCH

The clinical development process for a novel preventive vaccine: An overview

(2016) K Singh et al.   Journal of Postgraduate Medicine

Countering Vaccine Hesitancy

(2016) K. M. Edwards et al.   PEDIATRICS

Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity

(2016) Aleksandra Kowalczyk et al.   VACCINE

Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field

(2014) Dragomira Majhen et al.   HUMAN GENE THERAPY

Genetics of healthy aging and longevity

(2013) Angela R. Brooks-Wilson   HUMAN GENETICS

Animal models for highly pathogenic emerging viruses

(2013) David Safronetz et al.   Current Opinion in Virology

Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges

(2012) Iris Delrue et al.   Expert Review of Vaccines

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

(2012) Benjamin Petsch et al.   NATURE BIOTECHNOLOGY

A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease

(2012) Rachel L Graham et al.   NATURE MEDICINE

Developing mRNA-vaccine technologies

(2012) Thomas Schlake et al.   RNA Biology

Immunological mechanisms of vaccination

(2011) Bali Pulendran et al.   NATURE IMMUNOLOGY

Heterologous prime–boost vaccination

(2009) Shan Lu   CURRENT OPINION IN IMMUNOLOGY